← Back to Search

Brain Health Assessment for Dementia

N/A

Waitlist Available

Led By Deborah Barnes, PhD

Research Sponsored by Kaiser Permanente

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No prior diagnosis of dementia (defined from EHR diagnosis codes) and not receiving medications for dementia

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months after invitation mailed

Awards & highlights

Study Summary

This trial is testing a new, cheaper way to detect dementia in primary care settings.

Who is the study for?

This trial is for individuals who are active patients at participating clinics, have not been diagnosed with dementia or Alzheimer's Disease, and aren't on medications for these conditions. They must also have enough data available to calculate what's called an eRADAR score. People currently in hospice care cannot participate.Check my eligibility

What is being tested?

The study is testing a new strategy to detect dementia early in primary care settings by using a Brain Health Assessment tool. It aims to be low-cost and patient-friendly while improving the identification of cognitive issues.See study design

What are the potential side effects?

Since this trial involves an assessment rather than medication or invasive procedures, there are no direct physical side effects associated with the intervention being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have never been diagnosed with dementia nor am I on dementia medication.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months after invitation mailed

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months after invitation mailed

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after invitation mailed for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

New dementia diagnoses

Secondary outcome measures

Clinic "no shows"

Dementia medications

Healthcare utilization

+7 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Brain Health InterventionExperimental Treatment1 Intervention

Calculate eRADAR scores using EHR data to identify eligible individuals Invite eligible individuals for brain health assessment visit Enter results of brain health assessment visit into EHR Provide summary of results and recommended next steps to the Primary Care Physician and participant

Group II: Usual careActive Control1 Intervention

Individuals who meet eligibility criteria will receive usual care.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor

538 Previous Clinical Trials

24,110,366 Total Patients Enrolled

10 Trials studying Dementia

194,429 Patients Enrolled for Dementia

University of California, San FranciscoOTHER

2,505 Previous Clinical Trials

15,234,133 Total Patients Enrolled

34 Trials studying Dementia

200,364 Patients Enrolled for Dementia

Deborah Barnes, PhDPrincipal InvestigatorUniversity of California, San Francisco

2 Previous Clinical Trials

1,566 Total Patients Enrolled

1 Trials studying Dementia

1,350 Patients Enrolled for Dementia

Media Library

Brain Health Assessment Clinical Trial Eligibility Overview. Trial Name: NCT05356702 — N/A

Dementia Clinical Trial 2023: Brain Health Assessment Highlights & Side Effects. Trial Name: NCT05356702 — N/A

Brain Health Assessment 2023 Treatment Timeline for Medical Study. Trial Name: NCT05356702 — N/A

Dementia Research Study Groups: Brain Health Intervention, Usual care

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many research subjects are participating in this investigation?

"Affirmative. According to the clinicaltrials.gov database, this investigation is presently recruiting participants and was first launched on July 6th 2022 before being refreshed on August 29th 2022. The study aims to recruit 4050 individuals from a single medical facility."

Answered by AI

Is there a possibility of individuals joining this research project?

"According to information on clinicaltrials.gov, this medical investigation is actively searching for participants and was initially advertised on July 6th 2022 before being updated most recently on August 29th 2022."

Answered by AI

Recent research and studies

BMC GeriatricsJournal

Patient and Caregiver Perspectives on a Tool to Increase Recognition of Undiagnosed Dementia: A Qualitative Study

Palazzo, Lorella, Clarissa Hsu, Deborah E. Barnes, Marlaine Figueroa Gray, Mikael Anne Greenwood-Hickman, Eric B. Larson, and Sascha Dublin. 2021. “Patient and Caregiver Perspectives on a Tool to Increase Recognition of Undiagnosed Dementia: A Qualitative Study”. BMC Geriatrics. Springer Science and Business Media LLC. doi:10.1186/s12877-021-02523-0.

Journal of General Internal MedicineJournal

A Cohort Study of Healthcare Utilization in Older Adults with Undiagnosed Dementia

Lee, Sei J., Eric B. Larson, Sascha Dublin, Rod Walker, Zachary Marcum, and Deborah Barnes. 2017. “A Cohort Study of Healthcare Utilization in Older Adults with Undiagnosed Dementia”. Journal of General Internal Medicine. Springer Science and Business Media LLC. doi:10.1007/s11606-017-4162-3.

Journal of the American Geriatrics SocietyJournal

Development and Validation of Eradar: A Tool Using EHR Data to Detect Unrecognized Dementia

Barnes, Deborah E., Jing Zhou, Rod L. Walker, Eric B. Larson, Sei J. Lee, W. John Boscardin, Zachary A. Marcum, and Sascha Dublin. 2019. “Development and Validation of Eradar: A Tool Using EHR Data to Detect Unrecognized Dementia”. Journal of the American Geriatrics Society. Wiley. doi:10.1111/jgs.16182.

clinicaltrials.govStudy